跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Renaphos - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Renaphos
Approved
STANDARD
Renaphos
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4dbe5b7816dbafc1
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
4dbe5b7816dbafc1
Drug Approval Philippines Name
Renaphos
Product Name
Renaphos
Registration Number
DRP-10877-02
Brand Name
Renaphos
Generic Name
Sevelamer Carbonate
Dosage Form
Film-Coated Tablet
Dosage Strength
800 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
Littman Drug Corporation
Issuance Date
24 March 2022
Expiry Date
10 December 2026
Pharmacologic Category
Phosphate Binder
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4dbe5b7816dbafc1
Type
Standard
Back to Philippines FDA Approvals